1. Home
  2. NVGS vs IOVA Comparison

NVGS vs IOVA Comparison

Compare NVGS & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Navigator Holdings Ltd. (Marshall Islands)

NVGS

Navigator Holdings Ltd. (Marshall Islands)

HOLD

Current Price

$21.52

Market Cap

1.3B

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$3.32

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVGS
IOVA
Founded
1997
2007
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.4B
IPO Year
2013
2008

Fundamental Metrics

Financial Performance
Metric
NVGS
IOVA
Price
$21.52
$3.32
Analyst Decision
Strong Buy
Buy
Analyst Count
2
10
Target Price
$21.50
$9.00
AVG Volume (30 Days)
313.5K
14.0M
Earning Date
05-13-2026
05-07-2026
Dividend Yield
1.31%
N/A
EPS Growth
N/A
14.84
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$47.74
Revenue Next Year
N/A
$40.31
P/E Ratio
$13.06
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.63
$1.64
52 Week High
$21.65
$5.63

Technical Indicators

Market Signals
Indicator
NVGS
IOVA
Relative Strength Index (RSI) 65.39 41.44
Support Level $17.38 $2.05
Resistance Level N/A $4.33
Average True Range (ATR) 0.62 0.26
MACD 0.12 -0.04
Stochastic Oscillator 87.30 4.33

Price Performance

Historical Comparison
NVGS
IOVA

About NVGS Navigator Holdings Ltd. (Marshall Islands)

Navigator Holdings Ltd owns and operates liquefied gas carriers, which include a fleet of handysize liquefied gas carriers. The company also owns a share in an ethylene export marine terminal at Morgan's Point, Texas on the Houston Ship Channel (the Ethylene Export Terminal) through a joint venture (the Export Terminal Joint Venture). The company plays a vital role in the globalised liquefied gas supply chain, providing gas transportation solutions for energy companies, industrial users, and commodity traders.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: